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Summary
 
Clonally distributed inhibitory receptors negatively regulate natural killer (NK) cell function
via specific interactions with allelic forms of major histocompatibility complex (MHC) class I
molecules. In the mouse, the Ly-49 family of inhibitory receptors is found not only on NK
cells but also on a minor (NK1.1
 
1
 
) T cell subset. Using Ly-49 transgenic mice, we show here
that the development of NK1.1
 
1
 
 T cells, in contrast to NK or conventional T cells, is impaired
when their Ly-49 receptors engage self-MHC class I molecules. Impaired NK1.1
 
1
 
 T cell de-
velopment in transgenic mice is associated with a failure to select the appropriate CD1-reactive
T cell receptor repertoire. In normal mice, NK1.1
 
1
 
 T cell maturation is accompanied by ex-
tinction of Ly-49 receptor expression. Collectively, our data imply that developmentally regu-
lated extinction of inhibitory MHC-specific receptors is required for normal NK1.1
 
1
 
 T cell
maturation and selection.
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N
 
atural killer (NK)1.1
 
1
 
 T cells (1–4) are an unusual
subset of murine T cells that express a highly re-
stricted TCR-
 
a
 
/
 
b
 
 repertoire comprised of an invariant
V
 
a
 
14-J
 
a
 
281 chain and a predominant V
 
b
 
 domain (V
 
b
 
8.2).
Successful development of NK1.1
 
1
 
 T cells requires that
their canonical TCR interact with CD1, a nonclassical, MHC-
like molecule encoded outside of the MHC gene complex
(5–8). The developmental origin of NK1.1
 
1
 
 T cells is con-
troversial; nevertheless, it is widely accepted that they orig-
inate in the thymus and migrate to peripheral tissues such as
spleen and liver (4). Indeed, direct evidence for such a mi-
gration pattern has recently been obtained by in vivo adop-
tive transfer studies (9).
In contrast to conventional T cells, NK1.1
 
1
 
 T cells ex-
press several phenotypic markers usually associated with
NK cells such as NK1.1, CD122, and Ly-49. Ly-49 is a
multigene family (comprised of at least nine members, A–I)
encoding homodimeric C-type lectin-like receptors that
interact with specific alleles of MHC class I proteins (10).
In NK cells, it has been clearly shown that Ly-49–MHC
class I interaction negatively regulates effector functions
such as cytotoxicity and bone marrow graft rejection (11,
12). Although conventional TCR-
 
a
 
/
 
b
 
 cells in the mouse
do not normally express Ly-49 receptors, studies of Ly-49A
transgenic mice have demonstrated that proliferative re-
sponses of mature transgenic T cells to alloantigens can be
specifically inhibited by appropriate Ly-49–MHC class I
interactions (13), thus raising the possibility that signaling
via the TCR is susceptible to a Ly-49–dependent regula-
tory mechanism. This hypothesis is further supported by
recent data indicating that both cytokine secretion and the
cytotoxicity of NK1.1
 
1
 
 T cells are specifically inhibited
upon Ly-49–MHC class I interaction (14).
The potential ability of Ly-49 receptors to counteract
signaling by the TCR could also be of physiological rele-
vance for NK1.1
 
1
 
 T cell development. In this report, we
have tested this hypothesis by comparing putatively imma-
ture (thymic) and mature (liver) NK1.1
 
1
 
 T cells in normal
as well as Ly-49A transgenic mice. Our data indicate that
developmentally regulated extinction of Ly-49 receptor ex-
pression is required to allow appropriate TCR repertoire
selection and subsequent maturation of NK1.1
 
1
 
 T cells.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice were obtained from Harlan Olac (Bices-
ter, UK). Mice deficient for the transporter associated with anti-
gen processing (TAP1
 
2
 
) on a C57BL/6 background (15) were
obtained from The Jackson Laboratories (Bar Harbor, ME). The
production of Ly-49A transgenic mice has been described previ-
ously (13). These mice were established on a (CBA/J 
 
3
 
 C57BL/
6) F2 background and subsequently backcrossed to either
C57BL/6 (H-2
 
b
 
) or B10.D2 (H-2
 
d
 
). Transgenic and littermate
mice (fifth backcross) were analyzed in parallel.
 
Cells.
 
Liver mononuclear cells were prepared as previously
described (16). Thymocytes were depleted of heat stable antigen
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(HSA)
 
1
 
 cells by treatment with rat IgM mAb B2A2 plus rabbit
complement. Viable recovered cells (
 
z
 
1% of input) were purified
on a lympholyte-M gradient (Cedarlane Labs., Hornby, Ontario,
Canada).
 
Flow Microfluorometry.
 
HSA
 
low
 
 thymocytes or liver mononu-
clear cells were first incubated with unlabeled mAb 24G2 (anti–Fc
receptor) to block nonspecific binding, and were then triple stained
with combinations of the following mAb conjugates: anti-Ly49A-
FITC (A1); anti–Ly-49C/I-FITC (5E6); anti-Ly-49G2-FITC
(4D11); anti-V
 
a
 
2-FITC (B20.1); anti-V
 
a
 
3.2-FITC (RR3-16);
anti-V
 
a
 
8-FITC (B21.14); anti-V
 
a
 
11-FITC (RR8-1); anti-V
 
b
 
8.2-
FITC (F23.2); anti-NK1.1-PE (PK136); anti–TCR-
 
a
 
/
 
b
 
–biotin
(H57-597); and anti-Ly49C-biotin (4LO-3311). The latter two
mAbs were revealed with avidin-tricolor. All mAbs were ob-
tained from PharMingen (San Diego, CA), with the exception of
4LO-3311 (17). Samples were passed on a FACScan
 
Ò
 
 flow cy-
tometer (Becton Dickinson, San Jose, CA) gated to exclude non-
viable cells on the basis of light scatter. Data were analyzed by
LYSIS II software.
 
Results and Discussion
 
Although NK1.1
 
1
 
 T cells are present in small numbers
in other tissues, they have been primarily studied in thymus
and liver, where they account for 
 
z
 
25% of mature (HSA
 
low
 
)
TCR-
 
a
 
/
 
b
 
 cells in C57BL/6 mice (Fig. 1 
 
A
 
). Interestingly,
analysis of expression of Ly-49A, Ly-49C/I, and Ly-49G2
(the only inhibitory Ly-49 family members for which
mAbs are available) in these organs revealed that the pro-
portion of NK1.1
 
1
 
 T cells expressing each of the Ly-49
genes was substantially (two- to fivefold) higher in thymus
than in liver (Fig. 1 
 
B
 
). Conventional (i.e., NK1.1
 
2
 
) TCR-
 
a
 
/
 
b
 
 cells did not express Ly-49 receptors to any significant
degree (data not shown).
The reduced frequency of Ly-49
 
1
 
 NK1.1
 
1
 
 T cells in
liver as compared to thymus of normal mice could reflect a
requirement for loss of Ly-49 expression during NK1.1
 
1
 
 T
cell maturation. To test this hypothesis we used a trans-
genic mouse strain (13) in which all thymic and liver
NK1.1
 
1
 
 T cells express Ly-49A, as compared to the minor
(10–20%) Ly-49A
 
1
 
 subset of NK1.1
 
1
 
 T cells in nontrans-
genic littermates (Fig. 2 
 
A
 
). Moreover, endogenous and trans-
genic Ly-49A were expressed at similar levels on NK1.1
 
1
 
 T
cells (Fig. 2 
 
A
 
). As previously described (13), the transgene
is also expressed on all NK and T cells. In C57BL/6 (H-2
 
b
 
)
Ly-49A transgenic mice (where there is no ligand for Ly-
49A), NK1.1
 
1
 
 T cells as well as T and NK cells develop
normally in both thymus and liver as compared to non-
transgenic littermates (Fig. 2 
 
B
 
).
Figure 1. Differential expression of Ly-49
receptors by NK1.11 T cells in thymus and
liver. Thymocytes (HSAlow fraction) and
liver mononuclear cells from normal
C57BL/6 mice were triple stained with
mAbs against NK1.1 and TCR-a/b, and
Ly-49A, Ly-49C/I, or Ly-49G2. The cyto-
grams in A depict NK1.1 versus TCR-a/b
fluorescence. The mean percentage (6 SD)
of NK1.11 T cells (upper right quadrant) is in-
dicated. The histograms in B represent Ly-
49A, Ly-49C/I, or Ly-49G2 staining gated
on NK1.11 TCR-a/b1 cells. Numbers
represent the mean percentage of positive
cells (6 SD) in the indicated gates (5–10 ex-
periments).
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To ascertain whether NK1.1
 
1
 
 T cell development is af-
fected by Ly-49 engagement, we analyzed Ly-49A trans-
genic mice on a B10.D2 (H-2
 
d
 
) background where the
ligand for Ly-49A (H-2D
 
d
 
) is expressed. As shown in Fig. 2
 
A
 
, the cell surface level of Ly-49A was downmodulated to
a similar extent in NK1.1
 
1
 
 T cells of transgenic and wild-
type H-2
 
d
 
 (as compared to H-2
 
b
 
) mice. Similar results have
been observed for NK cells in these and other Ly-49A
transgenic mice (18). Importantly, both the frequency and
absolute number of liver NK1.1
 
1
 
 T cells was significantly
(threefold) reduced in H-2
 
d
 
 Ly-49A transgenic mice as
compared to nontransgenic littermates (Fig. 2 
 
B
 
). This ef-
fect was specific for the NK1.1
 
1
 
 T cell lineage since both
NK cells and conventional (NK1.1
 
2
 
) T cells developed
normally in the liver of H-2
 
d
 
 mice despite expression of the
Ly-49A transgene (Fig. 2 
 
B
 
). In the thymus, only a modest
reduction of NK1.1
 
1
 
 T cells was observed in H-2
 
d
 
 Ly-49A
transgenic mice as compared to littermates (Fig. 2 
 
B
 
).
If Ly-49 engagement in fact modifies signaling via the
TCR, then the impaired development of NK1.1
 
1
 
 T cells
in H-2
 
d
 
 Ly-49A transgenic mice might reflect a failure to
select the highly restricted CD1-specific TCR repertoire.
To address this issue, we compared TCR V
 
a
 
 and V
 
b
 
 use
in these mice with nontransgenic littermates. In normal
mice, NK1.1
 
1
 
 T cells in thymus and liver exhibit a TCR
repertoire that is highly skewed to V
 
a
 
14 and V
 
b
 
8.2 (1–4).
Since no reliable mAb to V
 
a
 
14 is currently available, we
assessed V
 
a
 
14 skewing in NK1.1
 
1
 
 T cells using a pool of
four anti-V
 
a
 
 mAbs that together detect 20–25% of the
normal TCR V
 
a
 
 repertoire. As shown in Fig. 3, both thy-
mic and liver NK1.1
 
1
 
 T cells from control H-2
 
d
 
 littermates
had a very high proportion of V
 
b
 
8.2
 
1
 
 cells and very few
cells staining with the Va mAb panel, as would be ex-
pected for cells expressing the canonical Va14/Vb8.2
TCR. Remarkably, however, liver NK1.11 T cells from
H-2d Ly-49A transgenic mice exhibited much lower levels
of Vb8.21 cells and much higher levels of cells expressing
the Va panel. Indeed, the Va and Vb repertoires of liver
NK1.11 T cells in these mice were not significantly differ-
ent from those of conventional (NK1.12) liver T cells (Fig.
3 B), indicating that the small proportion of NK1.11 T
cells that was still able to develop despite the presence of a
self-MHC–reactive Ly-49 receptor did not express the ca-
nonical Va14/Vb8.2 TCR.
In the thymus of H-2d Ly-49A transgenic mice, the
skewing towards Vb8.2 and Va14 in NK1.11 T cells was
reduced compared with littermate controls, but still highly
significant when compared with conventional (NK1.12) T
cells (Fig. 3 B). Thus, most thymic NK1.11 T cells bearing
the self-MHC–reactive Ly-49 receptor still expressed the
canonical TCR, whereas a minority did not. Perturbations
in the TCR Va and Vb repertoires of NK1.11 T cells
were strictly dependent upon Ly-49A–ligand interactions
and not related to expression of the transgene per se, since
NK1.11 T cells from the liver and thymus of H-2b Ly-49A
transgenic mice were indistinguishable from their nontrans-
genic littermates in terms of Vb8.2 and Va staining (Fig. 3 B).
Taken together, our data with Ly-49A transgenic mice
provide direct evidence that the development of NK1.11
T cells expressing self–MHC class–I-reactive Ly-49 recep-
tors is selectively impaired. Moreover, impaired develop-
ment of NK1.11 T cells is clearly correlated with a failure
Figure 2. Selectively impaired
NK1.11 T cell development in liver
of H-2d Ly-49A transgenic mice.
Thymocytes (HSAlow fraction) or
liver mononuclear cells from Ly-
49A transgenic mice or control lit-
termates on a H-2b (C57BL/6) or
H-2d (B10.D2) background were
analyzed by three-color flow mi-
crofluorometry for expression of
NK1.1, TCR-a/b, and Ly-49A. In
A, Ly-49A fluorescence profiles
gated on NK1.11 TCR-a/b1 cells
from normal (closed histograms) or
transgenic (open histograms) mice are
superimposed. The mean Ly-49A
fluorescence intensity of the trans-
genic NK1.11 T cells is indicated in
each case. The cytograms in B de-
pict NK1.1 versus TCR-a/b fluo-
rescence. Numbers represent the
mean percentage (6 SD) of T cells
(upper left), NK1.11 T cells (upper
right), and NK cells (lower right) in
transgenic and littermate mice on an
H-2b (n 5 4) or H-2d (n 5 7) back-
ground. The absolute numbers of
HSAlow thymocytes (1–2 3 106) and
liver mononuclear cells (4–5 3 106)
did not differ significantly among the different groups of mice. The lower proportion of liver NK1.11 T cells in H-2d versus H-2b littermate mice reflects
differences between the C57BL/6 and C57BL/10 genetic backgrounds (data not shown).
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to select the CD1-reactive canonical TCR, strongly argu-
ing that TCR signaling is perturbed by Ly-49 engagement
in this lineage. The molecular mechanism responsible for
impaired TCR signaling by NK1.11 T cells in Ly-49A
transgenic mice is currently unknown; however, by anal-
ogy with signaling events in NK cells (19–21) and conven-
tional T cells (22, 23), it is tempting to speculate that de-
phosphorylation of TCR-associated protein kinases (such
as ZAP-70) in NK1.11 T cells by Ly-49–associated phos-
phatases (such as SHP-1) leads to reduced TCR signaling
upon CD1 engagement, and hence to the lack of further
maturation.
Comparison of our data on normal and Ly-49A trans-
genic mice leads to a novel model for the regulation of
Ly-49 receptor expression during NK1.11 T cell develop-
ment. According to this scenario, immature NK1.11 T
cells expressing self-reactive Ly-49 receptors initially de-
velop in the thymus. However subsequent maturation of
these cells (and/or their export to peripheral tissues such as
the liver) requires loss of Ly-49 expression to avoid inter-
ference with TCR signaling if Ly-49 receptors are en-
gaged. Two distinct mechanisms could account for loss of
Ly-49 receptor expression during NK1.11 T cell matura-
tion. One possibility would be that Ly-49 expression is
simply extinguished in a developmentally regulated and
lineage-specific fashion. Alternatively, selection against
NK1.11 T cells expressing self-MHC–reactive Ly-49 re-
ceptors may occur.
Direct evidence that Ly-49 receptors are switched off
during normal NK1.11 T cell development was obtained
in TAP12 mice (15, 24), which express CD1 (the posi-
tively selecting ligand for the canonical TCR on NK1.11 T
cells), but not MHC class I (the ligand for Ly-49 inhibitory
receptors). Consistent with earlier studies (25, 26), the fre-
quency of NK1.11 T cells in thymus and liver of TAP12
mice (36 and 28%, respectively) was comparable with that
in wild-type controls. More importantly, the proportion of
NK1.11 T cells expressing Ly-49A, Ly-49C, and Ly-49G2
was reduced fivefold in liver (as compared with thymus) of
TAP12 mice (Fig. 4), similar to what had been observed
for wild-type mice (Fig. 1 B). Since all potential selecting
ligands for Ly-49 receptors are presumably absent in
TAP12 mice, these data argue definitively that extinction
of Ly-49 receptor expression must be occurring during
normal NK1.11 T cell development.
In conclusion, our data point to a novel lineage-specific
role and regulation of Ly-49 receptor expression during
normal NK1.11 T cell development. Although immature
NK1.11 T cells expressing self–MHC class I–reactive Ly-49
receptors extinguish Ly-49 expression in the course of their
maturation, NK cells do not. This dichotomy may reflect a
fundamental difference not only in the development, but
also in the function, of these two lymphocyte lineages.
Thus, mature NK cells are generally believed to require
expression of at least one self-reactive Ly-49 inhibitory re-
ceptor to avoid potential autoreactivity and to facilitate sur-
veillance of tissues rendered MHC class I–deficient by in-
fection or transformation (27). On the other hand, mature
Figure 3. Altered TCR repertoire selection in NK1.11 T cells from
H-2d Ly-49A transgenic mice. NK1.11 TCR-a/b1 cells from thymus or
liver of Ly-49A transgenic (Tg) mice and their littermate (LM) or wild-
type (WT) controls on either an H-2b or H-2d genetic background (gated
as in Fig. 2) were analyzed in the third color for expression of Vb8.2 or
Va (pool of Va2, Va3.2, Va8, and Va11). Histograms in A show repre-
sentative Vb8.2 and Va staining patterns gated on liver NK1.11 T cells
from H-2d mice. Data in B represent the mean percentage (6 SD) of
Vb8.21 or Va1 cells among NK1.11 T cells (black bars) or conventional
T cells (gray bars) in the indicated groups of mice (3–6 mice per group).
Where no error bars are indicated, the results represent the mean of two
mice.
Figure 4. Differential Ly-49
receptor expression by NK1.11
T cells in thymus and liver oc-
curs independently of MHC class
I. Thymocytes (HSAlow fraction)
and liver mononuclear cells from
TAP12 mice were triple stained
with mAbs against NK1.1 and
TCR-a/b, and Ly-49A, Ly-
49C, or Ly-49 G2. Data are ex-
pressed as the mean percentage
of Ly-491 cells among NK1.11
TCR-a/b1 cells (2 mice per
group).
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NK1.11 T cells, which recognize CD1 (probably in associ-
ation with a glycolipid; reference 28) via their canonical
TCR, may need to extinguish the expression of self-reac-
tive Ly-49 inhibitory receptors so that they can be activated
optimally by foreign antigens in any normal (i.e., MHC
class I–expressing) tissue.
Finally, in a more philosophical vein, one might ask why
Ly-49 receptors are expressed at all in the NK1.11 T cell
lineage if their subsequent extinction is required for correct
NK1.11 T cell maturation. One rather trivial explanation
would be that transient expression of Ly-49 receptors in
the NK1.11 T cell lineage represents an “evolutionary ac-
cident” resulting from a (hypothetical) close developmental
relationship to NK cells. Alternatively, Ly-49 receptor en-
gagement may play some positive role early in NK1.11 T
cell development, as suggested by the fact that some Ly-49
receptor family members (such as Ly-49D) have activating
properties (29). The third (and perhaps most interesting)
possibility could be that the presence of inhibitory Ly-49
receptors on NK1.11 T cells may be required at a particular
stage of development to establish a correct threshold for ac-
tivating signals delivered by the TCR or other (as yet uniden-
tified) receptors. In the latter context, it is interesting that
inefficient development of “NK1.1-like” T cells expressing
the canonical CD1-reactive TCR can occur in the absence
of Ly-49 (and NK1.1) expression in the thymus of mice
rendered deficient for the common cytokine g chain (30).
However, these cells are not found in peripheral tissues
such as the liver, consistent with the possibility that early
Ly-49 expression may be necessary for efficient and/or com-
plete NK1.11 T cell development.
We thank Dr. Suzanne Lemieux (Institut Armand-Frappier, Montreal, Canada) for the 4L0-3311 mAb and
Anna Zoppi for preparation of the manuscript.
Werner Held was supported by a grant (31-49137.96) and a START (Swiss Talents for Academic Research
and Teaching) fellowship from the Swiss National Science Foundation.
Address correspondence to H.R. MacDonald, Ludwig Institute for Cancer Research, Ch. des Boveresses
155, 1066 Epalinges, Switzerland. Phone: 41-21-692-59-89; Fax: 41-21-653-44-74; E-mail: hughrobson.
macdonald@isrec.unil.ch
Received for publication 12 March 1998.
References
1. MacDonald, H.R. 1995. NK1.11 T cell receptor ab1 cells:
new clues to their origin, specificity and function. J. Exp.
Med. 182:633–638.
2. Bix, M., and R.M. Locksley. 1995. Natural T cells. Cells that
co-express NKRP-1 and TCR. J. Immunol. 155:1020–1022.
3. Vicari, A.P., and A. Zlotnik. 1996. Mouse NK1.11 T cells: a
new family of T cells. Immunol. Today. 17:71–76.
4. Bendelac, A., M.N. Rivera, S.-H. Park, and J.H. Roark.
1997. Mouse CD1-specific NK1 T cells: development, spec-
ificity and function. Annu. Rev. Immunol. 15:535–562.
5. Bendelac, A., O. Lantz, M.E. Quimby, J.W. Yewdell, J.R.
Bennink, and R.R. Brutkiewicz. 1995. CD1 recognition by
mouse NK11 T lymphocytes. Science. 268:863–865.
6. Smiley, S.T., M.H. Kaplan, and M.J. Grusby. 1997. Immuno-
globulin E production in the absence of interleukin-4–secreting
CD1-dependent cells. Science. 275:977–979.
7. Chen, Y.-H., N.M. Chiu, M. Mandal, N. Wang, and C.-R.
Wang. 1997. Impaired NK11 T cell development and early
IL-4 production in CD1-deficient mice. Immunity. 6:459–467.
8. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S.
Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are defi-
cient in natural T cells that promptly produce IL-4. Immunity.
6:469–477.
9. Schulz, R.-J., A. Parkes, E. Mizoguchi, A.K. Bhan, and S.
Koyasu. 1996. Development of CD42 CD82 abTCR1
NK1.11 T lymphocytes. Thymic selection by self antigen. J.
Immunol. 157:4379–4389.
10. Yokoyama, W.M., and W.E. Seaman. 1993. The Ly-49 and
NKR-P1 gene families encoding lectin-like receptors on nat-
ural killer cells: the NK gene complex. Annu. Rev. Immunol.
11:613–635.
11. Karlhofer, F.M., R.K. Ribaudo, and W.M. Yokoyama.
1992. MHC class I alloantigen specificity of Ly-491 IL-2 ac-
tivated natural killer cells. Nature. 358:66–70.
12. Yu, Y.Y., T. George, J.R. Dorfman, J. Roland, V. Kumar,
and M. Bennett. 1996. The role of Ly49A and 5E6(Ly49C)
molecules in hybrid resistance mediated by murine natural
killer cells against normal T cell blasts. Immunity. 4:67–76.
13. Held, W., D. Cado, and D.H. Raulet. 1996. Transgenic ex-
pression of the Ly49A natural killer cell receptor confers class
I major histocompatibility complex (MHC)-specific inhibi-
tion and prevents bone marrow allograft rejection. J. Exp.
Med. 184:2037–2041.
14. Ortaldo, J.R., R. Winkler-Pickett, A.T. Mason, and L.H.
Mason. 1998. The Ly-49 family: regulation of cytotoxicity
and cytokine production in murine CD31 cells. J. Immunol.
160:1158–1165.
15. Van Kaer, L., P.G. Ashton-Rickardt, H.L. Ploegh, and S.
Tonegawa. 1992. TAP1 mutant mice are deficient in antigen
presentation, surface class I molecules, and CD4281 T cells.
Cell. 71:1205–1214.
16. Ohteki, T., and H.R. MacDonald. 1994. Major histocom-
patibility complex class I related molecules control the devel-
opment of CD4182 and CD4282 subsets of natural killer
1.11 T cell receptor–a/b1 cells in the liver of mice. J. Exp.
Med. 180:699–704.
2114 Role of Ly-49 Receptors in NK1.11 T Cell Development
17. Gosselin, P., Y. Lusignan, J. Brennan, F. Takei, and S. Le-
mieux. 1997. The NK2.1 receptor is encoded by Ly-49C
and its expression is regulated by MHC class I alleles. Int. Im-
munol. 9:533–540.
18. Fahlén, L., N.K.S. Khoo, M.R. Daws, and C.L. Sentman.
1997. Location-specific regulation of transgenic Ly49A re-
ceptors by major histocompatibility complex class I mole-
cules. Eur. J. Immunol. 27:2057–2065.
19. Burshtyn, D.N., A.M. Scharenberg, N. Wagtmann, S. Raja-
gopalan, K. Berrada, T. Yi, J.P. Kinet, and E.O. Long. 1996.
Recruitment of tyrosine phosphatase HCP by the killer cell
inhibitor receptor. Immunity. 4:77–85.
20. Fry, A.M., L.L. Lanier, and A. Weiss. 1996. Phosphoty-
rosines in the killer cell inhibitory receptor motif of NKB1
are required for negative signaling and for association with
protein tyrosine phosphatase 1C. J. Exp. Med. 184:295–300.
21. Olcese, L., P. Lang, F. Vély, A. Cambiaggi, D. Marguet, M.
Bléry, K.L. Hippen, R. Biassoni, A. Moretta, L. Moretta, et al.
1996. Human and mouse killer-cell inhibitory receptors re-
cruit PTP1C and PTP1D protein tyrosine phosphatases. J.
Immunol. 156:4531–4534.
22. Pani, G., K.-D. Fischer, I. Mlinaric-Rascan, and K.A. Simi-
novitch. 1996. Signaling capacity of the T cell antigen recep-
tor is negatively regulated by the PTP1C tyrosine phos-
phatase. J. Exp. Med. 184:839–852.
23. Plas, D.R., R. Johnson, J.T. Pingel, R.J. Matthews, M. Dal-
ton, G. Roy, A.C. Chan, and M.L. Thomas. 1996. Direct
regulation of ZAP-70 by SHP-1 in T cell antigen receptor
signaling. Science. 272:1173–1176.
24. Brutkiewicz, R.R., J.R. Bennink, J.W. Yewdell, and A.
Bendelac. 1995. TAP-independent, b2-microglobulin–depen-
dent surface expression of functional mouse CD1.1. J. Exp.
Med. 182:1913–1919.
25. Adachi, Y., H. Koseki, M. Zijlstra, and M. Taniguchi. 1995.
Positive selection of invariant Va141 T cells by non-major
histocompatibility complex–encoded class I–like molecules
expressed on bone-marrow–derived cells. Proc. Natl. Acad.
Sci. USA. 92:1200–1204.
26. Joyce, S., I. Negishi, A. Boesteanu, A.D. DeSilva, P. Sharma,
M.J. Chorney, D.Y. Loh, and L. Van Kaer. 1996. Expansion
of natural (NK11) T cells that express ab T cell receptors in
transporters associated with antigen presentation–1 null and
thymus leukemia antigen positive mice. J. Exp. Med. 184:
1579–1584.
27. Ljunggren H.G., and K. Kärre. 1990. In search of the “miss-
ing self”: MHC molecules and NK cell recognition. Immunol.
Today. 11:237–244.
28. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K.
Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al.
1997. CD1d-restricted and TCR-mediated activation of
Va14 NKT cells by glycosylceramides. Science. 278:1626–
1629.
29. Mason, L.H., S.K. Anderson, W.M. Yokoyama, H.R.C.
Smith, R. Winkler-Pickett, and J.R. Ortaldo. 1996. The Ly-
49D receptor activates murine natural killer cells. J. Exp.
Med. 184:2119–2128.
30. Lantz, O., L.I. Sharara, F. Tilloy, A. Andersson, and J.P.
DiSanto. 1997. Lineage relationships and differentiation of
natural killer (NK) T cells: intrathymic selection and interleu-
kin (IL)-4 production in the absence of NKR-P1 and Ly49
molecules. J. Exp. Med. 185:1395–1401.
